TG Therapeutics, Inc. (TGTX)

TG Therapeutics Revenue

TG Therapeutics had revenue of $240.34M in the quarter ending June 30, 2026, with 70.27% growth. This brings the company's revenue in the last twelve months to $799.54M, up 76.08% year-over-year. In the year 2025, TG Therapeutics had annual revenue of $616.29M with 87.32% growth.

• Revenue (ttm): $799.54M
• Revenue Growth: +76.08%
• P/S Ratio: 8.85
• Revenue / Employee: $2,003,850
• Employees: 399
• Market Cap: 7.06B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	616.29M	287.28M	87.32%
Dec 31, 2024	329.00M	95.34M	40.80%
Dec 31, 2023	233.66M	230.88M	8,290.02%
Dec 31, 2022	2.79M	-3.90M	-58.36%
Dec 31, 2021	6.69M	6.54M	4,300.66%
Dec 31, 2020	152.00K	-	-
Dec 31, 2019	152.00K	-	-
Dec 31, 2018	152.00K	-	-
Dec 31, 2017	152.00K	-	-
Dec 31, 2016	152.00K	-381.00	-0.25%
Dec 31, 2015	152.38K	-	-
Dec 31, 2014	152.38K	-	-
Dec 31, 2013	152.38K	133.33K	699.98%
Dec 31, 2012	19.05K	-	-
Dec 31, 2011	-	-	-
Dec 31, 2010	-	-	-
Dec 31, 2009	-	-	-
Dec 31, 2008	-	-	-
Dec 31, 2007	-	-	-
Dec 31, 2006	-	-	-

Data Source: Fiscal.ai Last updated: Aug 5, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 9, 2026

Data Sources Report a data error